DOCSLIB.ORG

DWS (CH) II Small and Mid Caps Switzerland

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DWS (CH) II Small and Mid Caps Switzerland Marketing Material DWS (CH) II Small and Mid Caps Switzerland Equity Funds - Europe - Regions/Countries August 2021 As at 31/08/2021 Fund Data Performance Investment Policy Performance - Share Class FD (in %) The goal of the sub-fund is primarily to achieve long-term growth in Swiss Francs through investment in a portfolio of stocks from Swiss issuers that are listed in a representative Swiss equities index of small and medium enterprises or the small and mid- cap subindex of a Swiss equities index (“the benchmark”). The investment strategy is based on a transparent and comprehensible investment process, focuses on stock selection. Fund Benchmark (since 09/08/2006): SPI EXTRA Total Return (RI) Past performance is no indication of current or future performance, and the performance data do not take account of the commissions and costs Fund Management's Comment incurred on the issue and redemption of units. For detailed comments on the fund and its corresponding markets please see the annual report. Cumulative performance (in %) - share class FD 1 m 1 y 3 y 5 y s. Inception YTD 3 y avg 5 y avg 2017 2018 2019 2020 CHF 3.0 42.7 36.1 77.7 421.8 29.6 10.8 12.2 29.9 -21.6 29.3 1.8 EUR 2.7 42.0 42.2 80.2 650.5 30.2 12.5 12.5 19.4 -18.6 33.7 2.2 BM IN CHF 2.5 34.9 39.1 90.5 284.2 23.7 11.6 13.8 29.7 -17.2 30.4 8.1 Further Characteristics (3 years) / VAR (1 year) - share class FD Volatility 18.36% Maximum Drawdown -21.26% VAR (99%/10 days) 7.23% Sharpe Ratio -- Information Ratio -0.16 Correlation Coefficient 0.97 Alpha -1.26% Beta 1.05 Tracking Error 4.41% Portfolio Analysis Breakdown by Sector (Equities) (in % of fund volume) Principal Holdings (Equities) (in % of fund volume) Portfolio Breakdown according to MSCI Chocoladefabriken Lindt & Sprungli AG (Consume 6.8 Industrials 33.7 Straumann Holding AG (Health Care) 6.3 Health Care 19.6 Kuehne + Nagel International AG (Industrials) 5.6 Information Technology 11.9 Financials 11.2 Sonova Holding AG (Health Care) 5.4 Consumer Staples 10.9 Logitech International SA (Information Technology) 5.1 Materials 7.7 Schindler Holding AG (Industrials) 5.0 Consumer Discretionary 2.5 Julius Baer Group Ltd (Financials) 4.5 Utilities 1.5 Morningstar Style-Box™ VAT Group AG (Industrials) 3.7 Market Capitalization SIG Combibloc Group AG (Materials) 3.4 Large Temenos AG (Information Technology) 3.4 Total 49.2 Mid Gross weighting, not adjusted for derivative positions. Gross weighting, not adjusted for derivative positions. Small Breakdown by Currency (in % of fund volume) Asset Allocation (in % of fund volume) Swiss franc 98.9 Equities 98.9 Value Growth Cash and other assets 1.1 Blend Investment Style Morningstar Category™ Switzerland Small/Mid-Cap Equity Ratings (As at: 30/07/2021) Morningstar Overall Rating™: ««« Currency structure of investments, excl. forward exchange transactions Note: The key terms are explained in the glossary. Page 1 / 6 Marketing Material DWS (CH) II Small and Mid Caps Switzerland Equity Funds - Europe - Regions/Countries August 2021 As at 31/08/2021 Portfolio Analysis Key Figures regarding the Fund's Assets Number of Shares 43 Dividend Yield (in %) 1.5 Ø Market Cap 12,397.6 Mio. CHF Cumulative performance (in %) 1 m 1 y 3 y 5 y s. YTD 3 y avg 5 y avg 2017 2018 2019 2020 Inception FD 3.0 42.7 36.1 77.7 421.8 29.6 10.8 12.2 29.9 -21.6 29.3 1.8 ID 3.0 42.7 36.1 -- 79.8 29.6 10.8 -- 29.9 -21.6 29.3 1.8 LD 2.9 41.1 31.7 68.6 254.7 28.6 9.6 11.0 28.5 -22.4 27.9 0.7 Fund Data Portfolio Manager Stefanie Scholtysik Assets 32.5 Mio. CHF Portfolio Manager since 01/01/2018 Fund Currency CHF Portfolio Management Company DWS CH AG Launch Date 15/06/2006 Portfolio Management Location Switzerland Fiscal Year End 31/12/2021 Management Company Vontobel Fonds Services AG Investor profile Risk-tolerant Legal Structure Investment fund under Swiss law Fund Domicile Switzerland Custodian RBC Investor Services Bank S.A., Esch-sur-Alzette, Share Classes Share Cur. ISIN Code Swiss Sec. Earnings Front-end Load Issue Price Redemption All-in-Fee Running costs / plus Minimum Class No. Price TER performance- Invest- related fee ment Amount FD CHF CH0025038479 2503847 Distribution 0.00% 459.59 459.59 0.500% * 0.50% (1) 0.00% 100,000 ID CHF CH0343877889 34387788 Distribution 0.00% 172.57 172.57 0.500% 0.50% (1) -- 1,000,000 LD CHF CH0122951905 12295190 Distribution 5.00% 351.66 351.66 1.600% 1.60% (1) -- -- *plus performance-related fee (1) The Total Expense Ratio (TER) generally includes all expense items charged to the Fund apart from transaction costs and performance fees. If the Fund invests a substantial part of its assets in target funds, the costs of the respective funds and payments received by them will also be taken into account. The Fund incurred the total expenses listed here in its last financial year which ended on 31/12/2017. They are subject to change from year to year. Address Note DWS CH AG Because of its composition or the techniques used by its managers, the fund features a high level of volatility. In other words, unit prices may fluctuate significantly in either direction within short periods of time. Hardstrasse 201 Previous month's rankings and ratings relating to German market. CH-8005 Zurich The collective investment scheme referred to in this document is a fund under Swiss law. Tel.: +41 44 224 77 00 Prospective investors can obtain the recent prospectus including the fund contract, the key investor information and the recent annual and semi- annual report free of charge from the fund management company, Vontobel Fonds Service AG, Gotthardstrasse 43, 8022 Zurich, from the Fax: +41 44 224 71 00 custodian bank, RBC Investor Services Bank S.A., Esch-sur-Alzette, Zurich Branch, Bleicherweg 7, 8027 Zurich, or from the main distributor in www.deutschefunds.ch Switzerland, DWS CH AG, Hardstrasse 201, CH-8005 Zurich. E-Mail: [email protected] Page 2 / 6 Legal Disclaimer Opportunities In accordance with the investment policy. Risks • The fund invests its assets in selected regions or sectors. This increases the risk that the fund may be negatively influenced by the economic and political conditions in the respective regions or sectors.• The fund invests in equities. Equities are subject to strong price fluctuations and thus also to the risk of price decreases.• The fund invests in equities of smaller companies. Equities of smaller companies are generally subject to higher price fluctuations than blue-chips. The reasons for this include their lower liquidity due to their lower market capitalization and smaller trading volume. As a result, equities or units of smaller companies may be more difficult to buy or sell than those of larger companies.• Due to its composition/the techniques used by the Fund management, the investment fund has significantly elevated volatility, i.e. the share price may be subject to significant fluctuations up or down within short periods of time. The share value may fall below the purchase price at which the customer acquired the share at any time. Investor profile: Risk-tolerant The Fund is intended for the risk-tolerant investor who, in seeking investments that offer targeted opportunities to maximize returns, can tolerate the unavoidable, and occasionally substaintial, fluctuations in the values of speculative investments. The high risks from volatility, as well as high credit risks, make it probable that the fund will lose value from time to time, and expectations of high returns and tolerance of risk are offset by the possibility of incurring significant losses of capital invested. Please note that the information from Morningstar and Lipper Leaders relates to the previous month. Morningstar Overall Rating™ © 2021 Morningstar, Inc. All rights reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results. General information When the custodian sets the price on the last trading day of the month there can be a difference of up to ten hours between the times at which the fund price and the benchmark are calculated. In the event of strong market movements during this period, this may result in the over- or understatement of the Fund's performance relative to the benchmark at the end of the month (this is referred to as the "pricing effect"). Subscriptions can only be made and units held in accordance with the terms set out in the current version of the sales prospectus, the prospectus and/or the key investor information. DWS publications may only be reproduced or published with the express written consent of Deutsche Bank AG or any of its subsidiaries. The information contained in this document is intended solely as a product description and does not constitute investment advice, an offer or a solicitation. The applicable fund agreement and/or the contractual conditions or management regulations, the prospectus and/or key inestor information or, if applicable, the annual and half-yearly reports, shall form the sole binding basis for the purchase of units in a collective investment scheme.
Load more

Recommended publications
  • Corporate Governance
    Business report Corporate governance Transparency is one of the key elements of good corporate governance, to which Sonova is committed. Good corporate governance is essential for Sonova and we strive for high standards in this field. What “good corporate governance” means is an evolving matter and we constantly monitor the latest changes to the requirements. Compliance is an integral element of our corporate culture and embedded in our core values. We therefore continued to strengthen the Sonova Group compliance program during the 2017/18 financial year, putting particular emphasis on integrating our acquired businesses into our compliance culture, designing new global compliance training, and updating our antibribery policy. Our continuing compliance efforts help us to live our values of ethical behavior and unquestionable integrity. At Sonova, corporate governance is based upon, and structured to conform with, relevant standards and practices. The company fulfils its legal duties under the Swiss Code of Obligations, the SIX Swiss Exchange Directive on Information relating to Corporate Governance, and the standards defined in the Swiss Code of Best Practice for Corporate Governance. This report describes the principles of corporate governance for the Sonova Group and provides background information on the Group’s executive officers and bodies as of March 31, 2018. All relevant documents can be accessed at the corporate governance section of the Sonova website: www.sonova.com/en/commitments/corporategovernance. For clarity and transparency, the compensation report is presented as a separate chapter of the annual report. Sonova Annual Report 2017/18 37 CORPORATE GOVERNANCE Group structure Operational group structure The Sonova Group is headquartered in Stäfa, Switzerland, and is active in over 100 countries.
    [Show full text]
  • Annual Report 2018 19 Table of Content
    FINANCIAL REPORT Annual Report 2018 19 Table of content Letter to shareholders 2 Our product and service offering 6 Strategy and businesses 10 Corporate governance 36 Compensation report 60 Financial review 96 5 year key figures 104 Consolidated financial statements 105 Financial statements of Sonova Holding AG 175 Investor information 188 Corporate Responsibility Report 190 Letter to shareholders Dear shareholders, 2018/19 marked another year of solid financial performance, posting further record levels of sales and profits to which all three businesses contributed. Moreover – and as expected – growth accelerated from the first half-year to the second, driven by the launch of a number of innovative products and solutions. Sonova affirmed its leading position in audiological performance with the release of the Marvel™ technology platform. Marvel takes full advantage of the unique connectivity enabled by our SWORD™ (Sonova Wireless One Radio Digital) chip and combines it with the proven convenience of our rechargeable solutions. We also made significant progress in our retail business, which we have renamed “audiological care” for one simple reason: care is what we deliver. The expert service We have made significant provided by our hearing care professionals adds key value for the consumer. progress in implementing our strategy. Our cochlear implants business launched a series of innovative new products to strengthen its leading position in this expanding market. Robert Spoerry You will find details of these and other strategic initiatives in the “strategy and businesses” section of this report. The global market in which we operate is poised for further growth, as developed countries see increasing demand from the “baby boomer” generation and developing countries begin to bridge the gap in hearing care provision.
    [Show full text]
  • FACTSHEET - AS of 29-Sep-2021 Solactive Switzerland 40 Equal Weight Index TR
    FACTSHEET - AS OF 29-Sep-2021 Solactive Switzerland 40 Equal Weight Index TR HISTORICAL PERFORMANCE 6,000 5,000 4,000 3,000 2,000 1,000 Jan-2000 Jan-2005 Jan-2010 Jan-2015 Jan-2020 Solactive Switzerland 40 Equal Weight Index TR CHARACTERISTICS ISIN / WKN DE000SLA98V4 / SLA98V Base Value / Base Date 1000 Points / 03.03.1999 Bloomberg / Reuters SOCH40ET Index / .SOCH40ET Last Price 5520.10 Index Calculator Solactive AG Dividends Included Index Type Total Return Calculation 09:00am to 10:30pm (CET), every 60 seconds Index Currency CHF History Available daily back to 03.03.1999 Index Members 40 FACTSHEET - AS OF 29-Sep-2021 Solactive Switzerland 40 Equal Weight Index TR STATISTICS 30D 90D 180D 360D YTD Since Inception Performance -6.87% -1.29% 6.88% 26.84% 16.30% 452.01% Performance (p.a.) - - - - - 7.86% Volatility (p.a.) 14.33% 11.91% 11.14% 12.42% 11.49% 18.86% High 5927.07 5927.07 5927.07 5927.07 5927.07 5927.07 Low 5498.67 5498.67 5111.72 4101.40 4734.43 549.01 Sharpe Ratio -4.04 -0.43 1.30 2.20 1.96 0.42 Max. Drawdown -7.23% -7.23% -7.23% -8.17% -7.23% -68.82% VaR 95 \ 99 -22.5% \ -33.9% -29.8% \ -57.3% CVaR 95 \ 99 -29.9% \ -44.8% -47.2% \ -78.4% COMPOSITION BY CURRENCIES COMPOSITION BY COUNTRIES CH 97.6% CHF 100.0% AT 2.4% TOP COMPONENTS AS OF 29-Sep-2021 Company Ticker Country Currency Index Weight (%) DUFRY AG DUFN SE Equity CH CHF 2.80% SWISSCOM AG SCMN SE Equity CH CHF 2.69% ALCON INC ALC SE Equity CH CHF 2.67% SONOVA HOLDING AG SOON SE Equity CH CHF 2.64% UBS GROUP AG UBSG SE Equity CH CHF 2.63% JULIUS BAER GRUPPE AG BAER SE Equity CH CHF 2.61% KUEHNE & NAGEL INTERNATIONAL AG KNIN SE Equity CH CHF 2.60% NESTLE SA NESN SE Equity CH CHF 2.60% SWISS LIFE HOLDING AG SLHN SE Equity CH CHF 2.60% CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG LISP SE Equity CH CHF 2.60% FACTSHEET - AS OF 29-Sep-2021 Solactive Switzerland 40 Equal Weight Index TR DISCLAIMER © Solactive AG, 2021.
    [Show full text]
  • Fund Holdings
    Wilmington International Fund as of 7/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS ISHARES MSCI CANADA ETF 3.48% TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 2.61% DREYFUS GOVT CASH MGMT-I 1.83% SAMSUNG ELECTRONICS CO LTD 1.79% SPDR S&P GLOBAL NATURAL RESOURCES ETF 1.67% MSCI INDIA FUTURE SEP21 1.58% TENCENT HOLDINGS LTD 1.39% ASML HOLDING NV 1.29% DSV PANALPINA A/S 0.99% HDFC BANK LTD 0.86% AIA GROUP LTD 0.86% ALIBABA GROUP HOLDING LTD 0.82% TECHTRONIC INDUSTRIES CO LTD 0.79% JAMES HARDIE INDUSTRIES PLC 0.78% DREYFUS GOVT CASH MGMT-I 0.75% INFINEON TECHNOLOGIES AG 0.74% SIKA AG 0.72% NOVO NORDISK A/S 0.71% BHP GROUP LTD 0.69% PARTNERS GROUP HOLDING AG 0.65% NAVER CORP 0.61% HUTCHMED CHINA LTD 0.59% LVMH MOET HENNESSY LOUIS VUITTON SE 0.59% TOYOTA MOTOR CORP 0.59% HEXAGON AB 0.57% SAP SE 0.57% SK MATERIALS CO LTD 0.55% MEDIATEK INC 0.55% ADIDAS AG 0.54% ZALANDO SE 0.54% RIO TINTO LTD 0.52% MERIDA INDUSTRY CO LTD 0.52% HITACHI LTD 0.51% CSL LTD 0.51% SONY GROUP CORP 0.50% ATLAS COPCO AB 0.49% DASSAULT SYSTEMES SE 0.49% OVERSEA-CHINESE BANKING CORP LTD 0.49% KINGSPAN GROUP PLC 0.48% L'OREAL SA 0.48% ASSA ABLOY AB 0.46% JD.COM INC 0.46% RESMED INC 0.44% COLOPLAST A/S 0.44% CRODA INTERNATIONAL PLC 0.41% AUSTRALIA & NEW ZEALAND BANKING GROUP LTD 0.41% STRAUMANN HOLDING AG 0.41% AMBU A/S 0.40% LG CHEM LTD 0.40% LVMH MOET HENNESSY LOUIS VUITTON SE 0.39% SOFTBANK GROUP CORP 0.39% NOVARTIS AG 0.38% HONDA MOTOR CO LTD 0.37% TOMRA SYSTEMS ASA 0.37% IMCD NV 0.37% HONG KONG EXCHANGES & CLEARING LTD 0.36% AGC INC 0.36% ADYEN
    [Show full text]
  • Fund Risk Management
    FUND RISK MANAGEMENT Monthly Report Umbrella Cosmos Lux International Net Asset Value 11,496,391.95 Sub-fund CHF Currency CHF August 2019 Portfolio date 26/08/2019 FUND ID Fund name Cosmos Lux International TNA end of period 11,496,391.95 NAV end of period 117.48 Sub-fund name CHF TNA start of period 11,830,504.83 NAV start of period 120.89 ISIN LU0989373237 TNA Variation -2.82% NAV Variation -2.82% Currency CHF Benchmark SWISS MARKET INDEX Subscriptions 0.00 FUND RISK PROFILE Low Redemptions 0.00 RISK MANAGEMENT COMMENTS Stale price overview No stale price. Operational risk No material NAV error occurred during the period. No massive redemption occurred during the period. Risk Metrics: Scorecard reporting 4Cs (based on NAV date) Leverage Counterparty risk Concentration risk Liquidity risk . <100% NAV <5% or 10% <10% >90% liquid day Investment Compliance dashboard Type of breach Description Origin Start date Close Date Active/Passive Impact Regulator reporting UCITS 50 (2) (a) Persistent overdraft Start of warning period 14/01/2019 21/01/2019 WARNING N/A N/A Investment Compliance specific NA Total Expense Ratio - Internal limit 3% As of 28/06/2019 (Quarterly): Without transaction fees B CAP: 2.78% Portfolio Turnover As of 28/06/2019 (Quarterly): 26.02% Please note that PTR displayed is calculated on an annual basis as specified in the CSSF circular 03/122. VaR - Leverage NA Liquidity Risk No issue to report. Investment Manager comments 1 FUND RISK MANAGEMENT Monthly Report Umbrella Cosmos Lux International Net Asset Value 11,496,391.95 Sub-fund CHF Currency CHF August 2019 Portfolio date 26/08/2019 Regulatory main limit checks Check result Indicator Check result Indicator Issuer Exposure < 10% NAV 5.48% Cash Counterparty Exposure < 20% NAV 1.55% OECD Govt Bond Exposure < 35% NAV NA OTC Counterparty Exposure NA 5/40 Rule 10.55% Aggregated Group Exposure 5.48% Borrowing limit < 10% NAV NA Cover Rule (liquid assets vs.
    [Show full text]
  • Portfolio of Investments
    PORTFOLIO OF INVESTMENTS Variable Portfolio – Partners International Growth Fund, September 30, 2020 (Unaudited) (Percentages represent value of investments compared to net assets) Investments in securities Common Stocks 99.4% Common Stocks (continued) Issuer Shares Value ($) Issuer Shares Value ($) Argentina 1.1% France 9.9% (a) MercadoLibre, Inc. 11,044 11,954,909 Air Liquide SA 33,000 5,230,820 Australia 3.3% Airbus Group SE(a) 115,226 8,356,836 Aristocrat Leisure Ltd. 382,096 8,332,956 Capgemini SE 100,870 12,941,155 Atlassian Corp. PLC, Class A(a) 34,922 6,348,471 Dassault Systemes 30,100 5,616,121 Cochlear Ltd. 21,100 3,014,527 L’Oreal SA 53,085 17,275,402 CSL Ltd. 90,068 18,605,054 LVMH Moet Hennessy Louis Vuitton SE 60,510 28,312,668 Total 36,301,008 Safran SA(a) 109,109 10,734,920 Canada 3.6% Sartorius Stedim Biotech 23,028 7,948,411 Alimentation Couche-Tard, Inc., Class B 179,500 6,250,922 Teleperformance SA 26,943 8,306,583 Brookfield Asset Management, Inc., Class A 129,004 4,264,872 Total SE 113,620 3,902,001 Canadian National Railway Co. 187,926 20,014,109 Total 108,624,917 Dollarama, Inc. 223,415 8,563,780 Germany 5.5% Total 39,093,683 Adidas AG(a) 18,700 6,039,018 China 9.0% Infineon Technologies AG 652,214 18,383,168 Alibaba Group Holding Ltd.(a) 950,520 34,894,654 Rational AG 13,768 10,799,191 CNOOC Ltd.
    [Show full text]
  • Wilmington Funds Holdings Template DRAFT
    Wilmington International Fund as of 5/31/2021 (Portfolio composition is subject to change) ISSUER NAME % OF ASSETS TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD 2.82% ISHARES MSCI CANADA ETF 2.43% SAMSUNG ELECTRONICS CO LTD 1.97% TENCENT HOLDINGS LTD 1.82% DREYFUS GOVT CASH MGMT-I 1.76% MSCI INDIA FUTURE JUN21 1.68% AIA GROUP LTD 1.05% HDFC BANK LTD 1.05% ASML HOLDING NV 1.03% ISHARES MSCI EUROPE FINANCIALS ETF 1.02% USD/EUR SPOT 20210601 BNYM 1.00% ALIBABA GROUP HOLDING LTD 0.95% DSV PANALPINA A/S 0.90% TECHTRONIC INDUSTRIES CO LTD 0.88% JAMES HARDIE INDUSTRIES PLC 0.83% INFINEON TECHNOLOGIES AG 0.73% BHP GROUP LTD 0.67% SIKA AG 0.64% MEDIATEK INC 0.60% NOVO NORDISK A/S 0.56% OVERSEA-CHINESE BANKING CORP LTD 0.55% CSL LTD 0.55% LVMH MOET HENNESSY LOUIS VUITTON SE 0.54% RIO TINTO LTD 0.53% DREYFUS GOVT CASH MGMT-I 0.53% MIDEA GROUP CO LTD 0.53% TOYOTA MOTOR CORP 0.52% PARTNERS GROUP HOLDING AG 0.52% SAP SE 0.51% ADIDAS AG 0.49% NAVER CORP 0.49% HITACHI LTD 0.49% MERIDA INDUSTRY CO LTD 0.47% ZALANDO SE 0.47% SK MATERIALS CO LTD 0.47% CHINA PACIFIC INSURANCE GROUP CO LTD 0.45% HEXAGON AB 0.45% LVMH MOET HENNESSY LOUIS VUITTON SE 0.44% JD.COM INC 0.44% TOMRA SYSTEMS ASA 0.44% DREYFUS GOVT CASH MGMT-I 0.44% SONY GROUP CORP 0.43% L'OREAL SA 0.43% EDENRED 0.43% AUSTRALIA & NEW ZEALAND BANKING GROUP LTD 0.43% NEW ORIENTAL EDUCATION & TECHNOLOGY GROUP INC 0.42% HUAZHU GROUP LTD 0.41% CRODA INTERNATIONAL PLC 0.40% ATLAS COPCO AB 0.40% ASSA ABLOY AB 0.40% IMCD NV 0.40% HUTCHMED CHINA LTD 0.40% JARDINE MATHESON HOLDINGS LTD 0.40% HONG KONG EXCHANGES
    [Show full text]
  • FTSE Developed Europe
    2 FTSE Russell Publications 19 August 2021 FTSE Developed Europe Indicative Index Weight Data as at Closing on 30 June 2021 Index weight Index weight Index weight Constituent Country Constituent Country Constituent Country (%) (%) (%) 1&1 AG 0.01 GERMANY Avast 0.03 UNITED Cnp Assurance 0.02 FRANCE 3i Group 0.14 UNITED KINGDOM Coca-Cola HBC AG 0.06 UNITED KINGDOM Aveva Group 0.05 UNITED KINGDOM A P Moller - Maersk A 0.1 DENMARK KINGDOM Coloplast B 0.19 DENMARK A P Moller - Maersk B 0.15 DENMARK Aviva 0.19 UNITED Colruyt 0.03 BELGIUM A2A 0.03 ITALY KINGDOM Commerzbank 0.07 GERMANY Aalberts NV 0.05 NETHERLANDS AXA 0.43 FRANCE Compagnie Financiere Richemont SA 0.55 SWITZERLAND ABB 0.51 SWITZERLAND B&M European Value Retail 0.06 UNITED Compass Group 0.33 UNITED KINGDOM ABN AMRO Bank NV 0.04 NETHERLANDS KINGDOM BAE Systems 0.21 UNITED Acciona S.A. 0.03 SPAIN Continental 0.14 GERMANY KINGDOM Accor 0.06 FRANCE ConvaTec Group 0.05 UNITED Baloise 0.06 SWITZERLAND Ackermans & Van Haaren 0.03 BELGIUM KINGDOM Banca Mediolanum 0.02 ITALY ACS Actividades Cons y Serv 0.06 SPAIN Covestro AG 0.1 GERMANY Banco Bilbao Vizcaya Argentaria 0.36 SPAIN Adecco Group AG 0.09 SWITZERLAND Covivio 0.04 FRANCE Banco Santander 0.58 SPAIN Adevinta 0.04 NORWAY Credit Agricole 0.14 FRANCE Bank Pekao 0.03 POLAND Adidas 0.63 GERMANY Credit Suisse Group 0.22 SWITZERLAND Bankinter 0.03 SPAIN Admiral Group 0.08 UNITED CRH 0.35 UNITED Banque Cantonale Vaudoise 0.02 SWITZERLAND KINGDOM KINGDOM Barclays 0.35 UNITED Adyen 0.62 NETHERLANDS Croda International 0.12 UNITED KINGDOM KINGDOM Aegon NV 0.06 NETHERLANDS Barratt Developments 0.09 UNITED Cts Eventim 0.03 GERMANY Aena SME SA 0.1 SPAIN KINGDOM Cyfrowy Polsat SA 0.02 POLAND Aeroports de Paris 0.03 FRANCE Barry Callebaut 0.07 SWITZERLAND Daimler AG 0.66 GERMANY Ageas 0.09 BELGIUM BASF 0.64 GERMANY Danone 0.37 FRANCE Ahold Delhaize 0.26 NETHERLANDS Bayer AG 0.53 GERMANY Danske Bank A/S 0.1 DENMARK AIB Group 0.02 IRELAND Bechtle 0.04 GERMANY Dassault Aviation S.A.
    [Show full text]
  • 14.75% P.A. CHF Barrier Reverse Convertible
    14.75% p.a. CHF Barrier Reverse Convertible Linked to worst of AMS AG, Logitech International SA and Temenos AG Issued by UBS AG, Zurich and Basel, Switzerland, acting through its London Branch Cash or physical settled; Kick In observation continuous SSPA Product Type: Barrier Reverse Convertible (1230) Valor: 59599217 / ISIN: CH0595992170 / WKN: UE6E19 / SIX Symbol: KIALDU This document is for marketing purposes only Public Offer Final Termsheet This document represents advertisement material pursuant to article 68 of the Swiss Federal Act on Financial Services (FinSA) and has been prepared for the purpose of an offer of the Products pursuant to FinSA and it must not be used for any other purpose or in any other context than for which it is prepared and provided. This document must not be used for, or in connection with, and does not constitute any offer to, or solicitation by, any person in any other jurisdiction than Switzerland or, if applicable, any other jurisdiction mentioned in the section “General Information / Public Offering” below. For information on the legally binding Product Documentation and the Key Information Document please refer to section “Product Documentation” below. The Product does not represent a participation in any of the collective investment schemes pursuant to article 7 et seq. of the Swiss Federal Act on Collective Investment Schemes (CISA) and thus does not require an authorisation of the Swiss Financial Market Supervisory Authority (FINMA). Therefore, investors in this Product are not eligible for the specific investor protection under the CISA. Moreover, investors in this Product bear the issuer risk. Furthermore, this Product does not benefit from any depositor protection under article 37a of the Swiss Federal Act on Banks and Savings Banks (Banking Act) or other forms of deposit insurance under any other law as might be applicable to this Product.
    [Show full text]
  • 2018 Compensation Report to a Principles Applicable to Performance-Related Pay and to the Consultative Vote at the 2019 Annual General Meeting
    84 Givaudan – 2018 Integrated Annual Report 85 Compensation report In this section 86 Compensation governance 87 Compensation principles 88 Compensation of Givaudan executives 93 Compensation of the Executive Committee 94 Compensation of the Board of Directors 96 Share ownership guidelines 96 Ownership of Givaudan securities 97 Report of the statutory auditor Givaudan – 2018 Integrated Annual Report 86 Compensation report Compensation report Attract, motivate and retain performance targets and related payouts under the annual incentives and share-based long-term incentives, while the Givaudan aims to attract, applicable performance criteria are set by the Board. motivate and retain a diverse The Compensation Committee is also responsible for pool of highly talented people to reviewing and approving individual compensation and benefits of each Executive Committee member as well as sustain its leadership position recommending compensation for the Board. within the flavour and fragrance The Compensation Committee consists of three independent industry. The Company’s members of the Board and is currently chaired by Prof. Dr-Ing. Werner Bauer. The Chief Executive Officer is regularly invited to compensation policies are an Compensation Committee meetings. The Head of Global Human Resources acts as secretary of the Compensation Committee. essential component of this The Chairman of the Compensation Committee may invite other strategy, and as such a key driver executives as appropriate. However, executives do not participate in discussions regarding their own compensation. of organisational performance. The Compensation Committee meets three to five times a year Our compensation programmes are aligned to our strategy and and informs the Board of its deliberations, recommendations and reflect the performance of the business and of individuals.
    [Show full text]
  • INSTITUTION for the ADVANCEMENT of LEARNING/Mcgill UNIVERSITY Non‐North American Equities │ As June 30, 2018
    THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/McGILL UNIVERSITY Non‐North American Equities │ As June 30, 2018 Non-North American Equities above $500,000 Publicly Traded and Held in Segregated Accounts (in Cdn $) EQUINOR ASA 4,667,657 NATIONAL GRID PLC 986,370 ROYAL DUTCH SHELL PLC 4,427,462 HEXAGON AB 973,115 AIA GROUP LTD 2,348,748 NEWCREST MINING LTD 956,441 NESTLE SA 2,264,202 GLENCORE PLC 951,817 KERING SA 2,061,100 ANHEUSER-BUSCH INBEV SA/NV 880,406 BNP PARIBAS SA 2,035,521 RECKITT BENCKISER GROUP PLC 879,511 ASML HOLDING NV 1,995,938 DAI-ICHI LIFE HOLDINGS INC 860,772 SHISEIDO CO LTD 1,974,775 TRINSEO SA 858,647 NOVO NORDISK A/S 1,966,727 RESONA HOLDINGS INC 847,661 AXA SA 1,884,013 ARISTOCRAT LEISURE LTD 835,169 BP PLC 1,818,219 TENARIS SA 816,060 WOLTERS KLUWER NV 1,745,904 UNILEVER NV 792,987 ROCHE HOLDING AG 1,685,016 TEMENOS AG 768,842 DAIKIN INDUSTRIES LTD 1,623,230 MIZUHO FINANCIAL GROUP INC 763,027 KEYENCE CORP 1,560,227 ORSTED A/S 755,181 LONZA GROUP AG 1,535,961 HERMES INTERNATIONAL 748,167 VONOVIA SE 1,520,087 LAZARD LTD 746,328 COMPASS GROUP PLC 1,510,233 SMURFIT KAPPA GROUP PLC 743,400 DASSAULT SYSTEMES SE 1,496,351 BANKINTER SA 734,902 KBC GROUP NV 1,479,694 MERCK KGAA 728,573 VINCI SA 1,473,769 EUROFINS SCIENTIFIC SE 725,827 DSV A/S 1,434,823 3I GROUP PLC 723,878 ASAHI GROUP HOLDINGS LTD 1,380,899 FERRARI NV 722,686 GALAXY ENTERTAINMENT GROUP 1,364,921 ING GROEP NV 717,618 HSBC HOLDINGS PLC 1,360,211 IBERDROLA SA 707,322 AMADEUS IT GROUP SA 1,344,621 LLOYDS BANKING GROUP PLC 704,166 JAZZ PHARMACEUTICALS PLC
    [Show full text]
  • Proposed Spin-Off of Alcon
    PROPOSED SPIN-OFF OF ALCON | A Proposed Spin-off of Alcon Shareholder Information Brochure General Meeting of Shareholders of Novartis AG February 28, 2019 Brochure dated as of January 30, 2019 B | PROPOSED SPIN-OFF OF ALCON Important Information This information brochure has been prepared exclusively for the We urge future holders of Alcon Shares to read the Form 20-F on shareholders of Novartis AG and holders of Novartis American file with the SEC or the SIX listing prospectus, once available, and Depositary Receipts (“ADRs”) in connection with the spin-off of Alcon familiarize themselves with the entire content, including the risk factors. proposed to the annual general meeting of Novartis shareholders to be held on February 28, 2019 (the “General Meeting”). The information set out herein and in any related materials is subject to updating, completion, revision, verification and/or amendment. This brochure is not an offer to sell or a solicitation of offers to Neither Novartis AG nor Alcon Inc. nor any of their affiliates or their purchase or subscribe for shares in Novartis AG or Alcon Inc. nor respective bodies, executives, employees and advisers are under any shall it or any part of it nor the fact of its distribution form the basis obligation to update or keep current the information contained in this of, or be relied on in connection with, any contract therefor. This brochure or to correct any inaccuracies except to the extent it would brochure does not constitute a listing prospectus as defined in the be required under applicable law or regulation.
    [Show full text]